-
-
-
-
-
-
-
Cantor Fitzgerald Starts AbCellera Biologics (ABCL) at Overweight
-
-
-
-
-
-
-
Leerink Partners Downgrades AbCellera Biologics (ABCL) to Market Perform
-
-
-
-
-
-
-
AbCellera (ABCL) Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
-
-
-
-
-
-
-
AbCellera Biologics (ABCL) PT Lowered to $5 at BMO Capital
-
-
-
-
-
-
-
Pre-Open Stock Movers 09/17: (CRVS) (ABCL) (BGNE) Higher; (PTGX) (GRTS) (X) Lower (more...)
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

